Results 21 to 30 of about 1,117,142 (241)

Active and Passive Immunization with Myelin Basic Protein as a Method for Early Treatment of Traumatic Spinal Cord Injury; a Meta-Analysis

open access: yesArchives of Academic Emergency Medicine, 2021
Introduction: Traumatic spinal cord injury (SCI), as a dangerous central nervous system damage, continues to threaten communities by imposing various disabilities and costs.
Mahmoud Yousefifard   +7 more
doaj   +1 more source

Passive immunization of the human vagina

open access: yesHuman Vaccines & Immunotherapeutics, 2022
The vagina is an excellent site for topical passive immunization, as access is relatively easy, and it is an enclosed space that has been shown to retain bioactive antibodies for several hours.
Deborah J. Anderson
doaj   +1 more source

IgY - turning the page toward passive immunization in COVID-19 infection (Review)

open access: yesExperimental and Therapeutic Medicine, 2020
The world is facing one of the major outbreaks of viral infection of the modern history, however, as vaccine development workflow is still tedious and can not control the infection spreading, researchers are turning to passive immunization as a good and ...
C. Constantin   +4 more
semanticscholar   +1 more source

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

open access: yeseLife, 2020
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from recovered patients, monoclonal antibodies against the viral S-protein, and soluble ...
P. Klasse, John P. Moore
semanticscholar   +1 more source

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

open access: yesMMWR. Morbidity and mortality weekly report, 2023
Respiratory syncytial virus (RSV) is the leading cause of hospitalization among U.S. infants. In July 2023, the Food and Drug Administration approved nirsevimab, a long-acting monoclonal antibody, for passive immunization to prevent RSV-associated lower ...
Jefferson M. Jones   +10 more
semanticscholar   +1 more source

The biophysical principles underpinning muco-trapping functions of antibodies

open access: yesHuman Vaccines & Immunotherapeutics, 2022
In addition to the classical immunological functions such as neutralization, antibody-dependent cellular cytotoxicity, and complement activation, IgG antibodies possess a little-recognized and under-utilized effector function at mucosal surfaces ...
Alison Schaefer, Samuel K. Lai
doaj   +1 more source

Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection

open access: yesFrontiers in Microbiology, 2018
New therapies are needed to prevent and treat Clostridium difficile infection and to limit the rise in antibiotic resistance. Besides toxins, several surface components have been characterized as colonization factors and have been shown as immunogenic ...
Séverine Péchiné   +3 more
doaj   +1 more source

Care and COVID 19: Lessons for liberals and neoliberals

open access: yesChild &Family Social Work, EarlyView., 2023
Abstract Within the liberal political traditions, care is regarded as a private matter, a problem of ethics rather than justice. Social justice is framed as an issue of economics (re/distribution), culture (recognition) and/or politics (representation).
Kathleen Lynch
wiley   +1 more source

Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases

open access: yesEmerging Infectious Diseases, 1999
Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces.
Larry Zeitlin   +2 more
doaj   +1 more source

Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections

open access: yesHuman Vaccines & Immunotherapeutics, 2023
New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in ...
Catherine Weil-Olivier   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy